236 related articles for article (PubMed ID: 14752241)
1. A study of VEGF and its receptors in two rat models of proteinuria.
Kanellis J; Levidiotis V; Khong T; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
Nephron Physiol; 2004; 96(1):P26-36. PubMed ID: 14752241
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis.
Horita Y; Miyazaki M; Koji T; Kobayashi N; Shibuya M; Razzaque MS; Cheng M; Ozono Y; Kohno S; Taguchi T
Nephrol Dial Transplant; 1998 Oct; 13(10):2519-28. PubMed ID: 9794554
[TBL] [Abstract][Full Text] [Related]
3. VEGF(165) mediates glomerular endothelial repair.
Ostendorf T; Kunter U; Eitner F; Loos A; Regele H; Kerjaschki D; Henninger DD; Janjic N; Floege J
J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis.
Fan L; Wakayama T; Yokoyama S; Amano O; Iseki S
Nephron; 2002 Jan; 90(1):95-102. PubMed ID: 11744811
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor is expressed in the adhesive lesions of experimental focal glomerular sclerosis.
Paizis K; Kirkland G; Khong T; Katerelos M; Fraser S; Kanellis J; Power DA
Kidney Int; 1999 Jun; 55(6):2310-21. PubMed ID: 10354279
[TBL] [Abstract][Full Text] [Related]
6. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
8. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
9. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression.
Kanellis J; Paizis K; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
Kidney Int; 2002 May; 61(5):1696-706. PubMed ID: 11967019
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
11. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
[TBL] [Abstract][Full Text] [Related]
12. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
Kim YH; Goyal M; Wharram B; Wiggins J; Kershaw D; Wiggins R
Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
[TBL] [Abstract][Full Text] [Related]
13. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
14. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
[TBL] [Abstract][Full Text] [Related]
16. Early changes in gene expression that influence the course of primary glomerular disease.
Clement LC; Liu G; Perez-Torres I; Kanwar YS; Avila-Casado C; Chugh SS
Kidney Int; 2007 Aug; 72(3):337-47. PubMed ID: 17457373
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy.
Paizis K; Kirkland G; Polihronis M; Katerelos M; Kanellis J; Power DA
Kidney Int; 1998 May; 53(5):1162-71. PubMed ID: 9573530
[TBL] [Abstract][Full Text] [Related]
18. Activation of nuclear factor-kappa B by podocytes in the autologous phase of passive Heymann nephritis.
Mudge SJ; Paizis K; Auwardt RB; Thomas RJ; Power DA
Kidney Int; 2001 Mar; 59(3):923-31. PubMed ID: 11231347
[TBL] [Abstract][Full Text] [Related]
19. Effects of podocyte injury on glomerular development.
Ma J; Rossini M; Yang HC; Zuo Y; Fogo AB; Ichikawa I
Pediatr Res; 2007 Oct; 62(4):417-21. PubMed ID: 17667850
[TBL] [Abstract][Full Text] [Related]
20. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
